Sign in

CIK 0001826457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$137
in 1 filing

Net −$137. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Bowen Matthew −$137 Principal Accounting Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2021-06-28 Behbahani Ali Director Conversion · Series A-2 convertible preferred stock −9,588,725 0
2021-06-28 Behbahani Ali Director Conversion · Series B convertible preferred stock −11,500,000 0
2021-06-28 Behbahani Ali Director Conversion · Series C convertible preferred Stock −2,361,912 0
2021-06-28 BASKETT FOREST 10% owner Conversion +2,715,968 2,715,968
2021-06-28 BASKETT FOREST 10% owner Conversion +3,257,328 5,973,296
2021-06-28 BASKETT FOREST 10% owner Conversion +669,002 6,642,298
2021-06-28 BASKETT FOREST 10% owner Purchase +1,050,000 $19.00 $19.9M 7,692,298
2021-06-28 BASKETT FOREST 10% owner Conversion · Series A-2 convertible preferred stock −9,588,725 0
2021-06-28 BASKETT FOREST 10% owner Conversion · Series B convertible preferred stock −11,500,000 0
2021-06-28 BASKETT FOREST 10% owner Conversion · Series C convertible preferred Stock −2,361,912 0
2021-06-28 New Enterprise Associates 17, L.P. 10% owner Conversion +2,715,968 2,715,968
2021-06-28 New Enterprise Associates 17, L.P. 10% owner Conversion +3,257,328 5,973,296
2021-06-28 New Enterprise Associates 17, L.P. 10% owner Conversion +669,002 6,642,298
2021-06-28 New Enterprise Associates 17, L.P. 10% owner Purchase +1,050,000 $19.00 $19.9M 7,692,298
2021-06-28 New Enterprise Associates 17, L.P. 10% owner Conversion · Series A-2 convertible preferred stock −9,588,725 0
2021-06-28 New Enterprise Associates 17, L.P. 10% owner Conversion · Series B convertible preferred stock −11,500,000 0
2021-06-28 New Enterprise Associates 17, L.P. 10% owner Conversion · Series C convertible preferred Stock −2,361,912 0
2021-06-28 Bolzon Bradley J PhD Director Conversion +6,515,869 6,799,115
2021-06-28 Bolzon Bradley J PhD Director Conversion +1,940,043 1,940,043
2021-06-28 Bolzon Bradley J PhD Director Purchase +157,895 $19.00 $3.0M 2,097,938

Page 14 of 16 · 310 trades